DEF 14A: FlexShopper Seeks Stockholder Approval for Increased Share Authorization and Amended Equity Plan

Sentiment:

Proxy Statement


FlexShopper is holding its 2024 Annual Meeting of Stockholders on October 7, 2024, to vote on key proposals including increasing authorized common stock and amending the equity compensation plan.

Capital raiseThe company is seeking to increase the number of authorized shares of common stock from 40,000,000 to 100,000,000.The increase in authorized shares is intended to provide the Board with authority to issue additional shares from time to time as the Board deems necessary.The company may use the additional shares for shelf registrations and acquisitions of businesses.

Summary

  • FlexShopper, Inc. is holding its 2024 Annual Meeting of Stockholders on October 7, 2024, at its executive offices in Boca Raton, Florida.
  • Stockholders will vote on several proposals, including the election of five directors, an amendment to the company's charter to increase the authorized shares of common stock from 40,000,000 to 100,000,000, and an advisory vote on executive compensation.
  • Additionally, stockholders will vote on an amendment to the 2018 Omnibus Equity Compensation Plan to increase the number of shares reserved for issuance and to ratify the appointment of Grant Thornton, LLP as the independent registered public accounting firm for 2024.
  • The Board of Directors recommends voting 'FOR' all proposals.
  • The record date for determining stockholders eligible to vote is August 16, 2024.
  • As of the record date, there were 21,597,371 shares of common stock, 170,332 shares of Series 1 Preferred Stock, and 21,952 shares of Series 2 Preferred Stock outstanding, representing a total of 27,668,297 voting shares.

Sentiment

Score: 6

Explanation: The document is neutral in tone, primarily presenting factual information about the upcoming annual meeting and proposals. While the proposals themselves could have positive or negative implications depending on stockholder perspectives, the document itself does not express a strong positive or negative sentiment.

Positives

  • The proposed increase in authorized shares provides the company with greater flexibility to address strategic and liquidity needs, including potential acquisitions.
  • The amendment to the 2018 Omnibus Equity Compensation Plan allows the company to continue attracting and retaining key personnel through equity-based incentives.
  • The Board of Directors is actively engaged in corporate governance, with independent directors comprising a majority of the board and key committees.
  • The company has a clawback policy in place to recover erroneously awarded compensation from executive officers and employees.

Negatives

  • Increasing the authorized number of shares of common stock could result in dilution of net income per share, book value per share, and voting rights of existing stockholders.
  • The company has had related party transactions, including loans from officers and directors, which could present potential conflicts of interest.
  • There were instances of delinquent Section 16(a) filings by some directors and executive officers during 2023, indicating potential weaknesses in compliance procedures.

Risks

  • The increase in authorized shares may deter unwanted takeovers, but could also make it more difficult to remove current management.
  • Related party transactions, while disclosed, could raise concerns about fairness and potential conflicts of interest.
  • Failure to maintain effective internal controls could lead to financial misstatements and regulatory scrutiny.

Future Outlook

The increase in authorized shares of common stock is intended to provide the Board with the authority to issue additional shares from time to time as the Board deems necessary to provide flexibility in addressing the strategic and liquidity needs of the Company.

Industry Context

Companies in various industries often seek to increase their authorized share capital to provide flexibility for future financing, acquisitions, and other corporate purposes. Equity compensation plans are also a common tool for attracting and retaining talent in competitive markets.

Comparison to Industry Standards

  • Increasing authorized shares is a common practice among publicly traded companies to provide flexibility for future capital needs.
  • Equity compensation plans are widely used in the industry to align the interests of employees and executives with those of shareholders.
  • The specific terms of executive compensation packages, including base salary, bonus, and equity awards, are typically benchmarked against peer companies of similar size and industry.

Related Party Transactions

  • Amendments to Credit Agreement involving Waterfall Asset Management, LLC.
  • Loans Payable to an Officer and Director NRNS Note.
  • 122 Partners Note.

Stakeholder Impact

  • Approval of the proposals could impact shareholders through potential dilution or increased flexibility for the company's strategic initiatives.
  • Employees and executives could be affected by changes to the equity compensation plan.
  • The company's financial performance and strategic direction could be influenced by the outcome of the votes.

Next Steps

  • Stockholders should review the proxy materials and vote on the proposals.
  • The company will hold the Annual Meeting of Stockholders on October 7, 2024.
  • The company will file a Current Report on Form 8-K with the SEC to announce the voting results within four business days following the meeting.

Key Dates

DateDescription
March 1, 2018The 2018 Omnibus Equity Compensation Plan was adopted by the Board.
April 26, 2018The 2018 Omnibus Equity Compensation Plan was approved by stockholders.
January 25, 2019FlexShopper, LLC entered into a subordinated debt financing letter agreement with 122 Partners, LLC.
February 21, 2019Amendment No. 1 to the 2018 Plan was approved by the Board.
May 2, 2019Amendment No. 1 to the 2018 Plan was approved by stockholders.
April 24, 2020Amendment No. 2 to the 2018 Plan was approved by the Board.
June 10, 2020Amendment No. 2 to the 2018 Plan was approved by stockholders.
March 31, 2021Amendment No. 3 to the 2018 Plan was approved by the Board.
June 9, 2021Amendment No. 3 to the 2018 Plan was approved by stockholders.
January 29, 2021Amendment to the Credit Agreement extended the Commitment Termination Date to April 1, 2024.
June 28, 2022The Audit Committee approved the appointment of Grant Thornton LLP as the company's independent registered public accounting firm.
August 8, 2023Amendment No. 4 to the 2018 Plan was approved by the Board.
September 6, 2023The Subordinated Promissory Note Borrower paid all the principal and interest outstanding as of that date.
November 1, 2023Amendment No. 4 to the 2018 Plan was approved by stockholders.
March 27, 2024The Company refinanced all the obligations under the Credit Agreement owed to the Administrative Agent and the Lenders, and all liens held by any of the Lenders, or the Administrative Agent were discharged and released.
August 16, 2024Record date for determining stockholders eligible to vote at the annual meeting.
August 27, 2024The Board approved Amendment No. 5 to the 2018 Plan, subject to stockholder approval.
August 31, 2024Date for securities ownership of certain beneficial owners and management.
September 9, 2024Proxy statement is being mailed to stockholders on or about this date.
October 7, 2024Date of the 2024 Annual Meeting of Stockholders.

Keywords

proxy statement, annual meeting, stockholders, authorized shares, equity compensation plan, directors, executive compensation, Grant Thornton, corporate governance, FlexShopper

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.